Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma

BACKGROUND: The evolution of radiotherapy over recent decades has reintroduced the hypofractionation for many tumor sites with similar outcomes to those of conventional fractionated radiotherapy. The use of hypofractionation in locally advanced head and neck cancer (LAHNC) has been already used, how...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacinto, Alexandre Arthur, Batalha Filho, Eronides Salustiano, Viana, Luciano de Souza, De Marchi, Pedro, Capuzzo, Renato de Castro, Gama, Ricardo Ribeiro, Boldrini Junior, Domingos, Santos, Carlos Roberto, Pinto, Gustavo Dix Junqueira, Dias, Josiane Mourão, Canton, Heloisa Pelisser, Carvalho, Raiany, Radicchi, Lucas Augusto, Bentzen, Soren, Zubizarreta, Eduardo, Carvalho, Andre Lopes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199702/
https://www.ncbi.nlm.nih.gov/pubmed/30352576
http://dx.doi.org/10.1186/s12885-018-4893-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199702/
https://www.ncbi.nlm.nih.gov/pubmed/30352576
http://dx.doi.org/10.1186/s12885-018-4893-5

Ejemplares similares